首页> 美国卫生研究院文献>Springer Open Choice >A longitudinal study of patients with cirrhosis treated with L-ornithine L-aspartate examined with magnetization transfer diffusion-weighted imaging and magnetic resonance spectroscopy
【2h】

A longitudinal study of patients with cirrhosis treated with L-ornithine L-aspartate examined with magnetization transfer diffusion-weighted imaging and magnetic resonance spectroscopy

机译:用磁化转移弥散加权成像和磁共振波谱检查对L-鸟氨酸L-天冬氨酸治疗肝硬化患者的纵向研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The presence of overt hepatic encephalopathy (HE) is associated with structural, metabolic and functional changes in the brain discernible by use of a variety of magnetic resonance (MR) techniques. The changes in patients with minimal HE are less well documented. Twenty-two patients with well-compensated cirrhosis, seven of whom had minimal HE, were examined with cerebral 3 Tesla MR techniques, including T1- and T2-weighted, magnetization transfer and diffusion-weighted imaging and proton magnetic resonance spectroscopy sequences. Studies were repeated after a 4-week course of oral L-ornithine L-aspartate (LOLA). Results were compared with data obtained from 22 aged-matched healthy controls. There was no difference in mean total brain volume between patients and controls at baseline. Mean cerebral magnetization transfer ratios were significantly reduced in the globus pallidus and thalamus in the patients with cirrhosis irrespective of neuropsychiatric status; the mean ratio was significantly reduced in the frontal white matter in patients with minimal HE compared with healthy controls but not when compared with their unimpaired counterparts. There were no significant differences in either the median apparent diffusion coefficients or the mean fractional anisotropy, calculated from the diffusion-weighted imaging, or in the mean basal ganglia metabolite ratios between patients and controls. Psychometric performance improved in 50 % of patients with minimal HE following LOLA, but no significant changes were observed in brain volumes, cerebral magnetization transfer ratios, the diffusion weighted imaging variables or the cerebral metabolite ratios. MR variables, as applied in this study, do not identify patients with minimal HE, nor do they reflect changes in psychometric performance following LOLA.Electronic supplementary materialThe online version of this article (doi:10.1007/s11011-016-9881-3) contains supplementary material, which is available to authorized users.
机译:明显的肝性脑病(HE)的存在与大脑的结构,代谢和功能变化有关,可通过使用各种磁共振(MR)技术来辨别。 HE最少的患者的变化记录较少。使用脑3 Tesla MR技术(包括T1和T2加权,磁化转移和扩散加权成像以及质子磁共振波谱序列)检查了22例肝硬化补偿良好的患者,其中7例的HE最低。口服L-鸟氨酸L-天门冬氨酸(LOLA)4周疗程后重复研究。将结果与从22位年龄匹配的健康对照中获得的数据进行比较。基线时患者与对照组之间的平均总脑容量没有差异。不论神经精神状态如何,肝硬化患者的苍白球和丘脑平均磁化转移率均明显降低;与健康对照组相比,HE最低的患者额叶白质的平均比率显着降低,但与未受损的对照组相比则没有。由扩散加权成像计算得出的中位表观扩散系数或平均分数各向异性或患者与对照之间的平均基底神经节代谢率均无显着差异。在LOLA后发生最小程度HE的患者中,其心理测量性能得到了改善,但50%的患者在脑容量,脑磁化转移率,弥散加权成像变量或脑代谢物率方面均未见明显变化。这项研究中使用的MR变量无法识别出HE最低的患者,也无法反映出LOLA后心理测验表现的变化。电子补充材料本文的在线版本(doi:10.1007 / s11011-016-9881-3)包含补充材料,授权用户可以使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号